CRISPR Therapeutics AG Quarterly Common Stock, Shares Authorized from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
CRISPR Therapeutics AG quarterly Common Stock, Shares Authorized history and growth rate from Q4 2015 to Q3 2024.
  • CRISPR Therapeutics AG Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 132M shares.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 132M Sep 30, 2024 10-Q 2024-11-05
Q2 2024 132M Jun 30, 2024 10-Q 2024-08-05
Q1 2024 130M -19.9M -13.2% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 127M -23.8M -15.8% Dec 31, 2023 10-Q 2024-11-05
Q1 2023 150M +4.98M +3.43% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 150M +4.98M +3.43% Dec 31, 2022 10-K 2024-02-21
Q3 2022 150M +4.98M +3.43% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 150M +4.98M +3.43% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 145M +30.2M +26.2% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 145M +30.2M +26.2% Dec 31, 2021 10-K 2023-02-21
Q3 2021 145M +30.2M +26.2% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 145M +30.2M +26.2% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 115M +11.3M +10.8% Mar 31, 2021 10-Q 2021-04-27
Q4 2020 115M +11.3M +10.8% Dec 31, 2020 10-K 2022-02-15
Q3 2020 115M +59.5M +107% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 115M +59.7M +108% Jun 30, 2020 10-Q 2020-07-27
Q1 2020 104M +50.6M +94.8% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 104M +13.6M +15% Dec 31, 2019 10-K 2021-02-16
Q3 2019 55.7M +3.78M +7.29% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 55.4M +7.92M +16.7% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 53.3M +6.16M +13.1% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 90.3M +49.3M +120% Dec 31, 2018 10-K 2020-02-12
Q3 2018 51.9M +11M +26.9% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 47.5M +6.96M +17.2% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 47.2M +6.91M +17.2% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 41.1M +839K +2.09% Dec 31, 2017 10-K 2019-02-25
Q3 2017 40.9M +35.2M +622% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 40.6M Jun 30, 2017 10-Q 2017-08-10
Q1 2017 40.3M Mar 31, 2017 10-Q 2017-05-11
Q4 2016 40.3M +34.7M +628% Dec 31, 2016 10-K 2018-03-08
Q3 2016 5.66M Sep 30, 2016 10-Q 2016-11-22
Q4 2015 5.53M Dec 31, 2015 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.